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Abstract. The progressive loss of skeletal muscle mass is a 
serious pathophysiological problem in the elderly, which 
warrants detailed biochemical studies into the underlying 
mechanism of age-related fiber degeneration. Over the last 
few years, mass spectrometry (MS)-based proteomics has 
identified a considerable number of new biomarkers of muscle 
aging in humans and animal models of sarcopenia. However, 
interpretation of the proteomic findings is often compli-
cated by technical and biological limitations. Although gel 
electrophoresis-based approaches represent a highly sensitive 
analytical way for the large-scale and high-throughput survey 
of global changes in skeletal muscle proteins during aging, 
often the presence of components with an isoelectric point in 
the basic range is underestimated. We, therefore, carried out 
a comparative subproteomic study of young versus aged rat 
muscle focusing on potential changes in muscle proteins with 
an alkaline isoelectric point, using a combination of offgel 
electrophoresis and two-dimensional (2D) slab gel electro-
phoresis. Offgel electrophoresis was successfully applied as 
a prefractionation step to enrich basic protein species from 
crude tissue extracts representing young adult versus senescent 
muscle specimens. Proteomics has demonstrated alterations 
in a small cohort of basic proteins during muscle aging. The 
mass spectrometric identification of altered proteins and 
immunoblotting revealed a decrease in the glycolytic enzyme 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and a 
concomitant increase in mitochondrial creatine kinase (CK) 
and ubiquinol cytochrome-c reductase. This agrees with the 
idea of a glycolytic-to-oxidative shift during muscle aging, 
which is indicative of an overall fast-to-slow transition process 
in senescent rat muscle. Thus, alterations in the abundance 
of metabolic enzymes appear to play a central role in the 
molecular pathogenesis of age-dependent muscle wasting.
Introduction
The progressive wasting of skeletal muscle tissue plays a 
crucial pathophysiological role in frailty, fragility and loss of 
independence in aged people (1). In the majority of humans, 
skeletal muscle mass and contractile strength decline during 
aging (2), making sarcopenia a striking feature of the senescent 
organism (3). A sedentary life style clearly promotes muscle 
degeneration in elderly patients (4). Functional impairments of 
the neuromuscular system are believed to be multi-factorial, 
but it is not clear whether a pathobiochemical hierarchy exists 
within these aberrant pathways (5,6). The exact molecular 
mechanisms underlying primary muscle degeneration, 
secondary effects, impaired repair cycles and physiological 
adaptations of aging muscle are still elusive. Although 
considerable inter-individual differences exist in elderly 
people with respect to the degree of muscle wasting (7,8), 
the age-related impairment of innervation and concomitant 
excitation-contraction uncoupling appears to be an intractable 
consequence of advanced age (9).
Although it is encouraging that a protein-rich diet and 
regular physical activity can at least partially diminish severe 
fibre degeneration (10-12), the symptoms of sarcopenia may 
be aggravated by unrelated pathologies. This includes cancer, 
traumatic injury, type 2 diabetes, metabolic syndrome, renal 
failure, chronic obstructive pulmonary disease and conges-
tive heart failure (13-15). Thus, the clinical prevalence 
of sarcopenia in the aging population requires detailed 
physiological, biochemical and genetic investigations into the 
molecular pathogenesis of age-related muscle degeneration. In 
the present study, we used electrophoresis-based proteomics 
to study potential changes in muscle protein abundance in 
an established animal model of sarcopenia, the aged Wistar 
rat (16). Over the last few years, a variety of proteomic 
approaches have determined changes in animal and human 
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muscle proteins during aging (17). This includes the mass 
spectrometric (MS) identification of altered protein nitration 
(18), protein phosphorylation (19), protein carbonylation (20) 
and protein glycosylation (21), as well as changes in the abun-
dance of muscle proteins using crude tissue extracts (22-27) 
and subcellular fractions, such as myofibrils (28), integral 
membrane proteins (29) and mitochondria (30).
Modifications in mitochondria have previously been 
implicated in the natural aging process (31), including cellular 
senescence in contractile tissues (32). Functional changes 
and altered expression patterns of mitochondrial proteins 
in aged skeletal muscle have been confirmed by proteomic 
investigations, as reviewed by Staunton et al (33). However, 
a potential problem with the gel electrophoretic separation of 
the urea-soluble portion of the skeletal muscle proteome is 
that the presence of proteins that exhibit an isoelectric point 
in the basic range is often underestimated (34). To address this 
technical problem, we carried out an offgel electrophoretic 
pre-fractionation step prior to standard 2D gel electrophoresis. 
The offgel approach fractionates protein populations in solu-
tion by isoelectric focusing (IEF) (35) and can therefore be 
employed to separate proteins with small differences in their 
isoelectric point (36). Offgel electrophoresis has been success-
fully applied to studying extraocular muscle specimens (37) 
and was used here for a comparative subproteomic study of 
young adult versus aged rat muscle. Our proteomic survey 
has focused on potential changes in proteins with a basic 
isoelectric point and showed an increase in mitochondrial 
creatine kinase (CK) and ubiquinol cytochrome-c reductase 
and a decrease in glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH). These findings agree with the idea that muscle 
aging is associated with a glycolytic-to-oxidative shift and that 
changes in key metabolic enzymes are involved in age-related 
muscle weakness.
Materials and methods
Materials. Chemicals and materials for the offgel and 2D 
gel electrophoretic analysis of muscle proteins, including 
IEF pH gradient strips and ampholytes, were obtained from 
Agilent Technologies (Santa Clara, CA, USA) and Amersham 
Bioscience/GE Healthcare (Little Chalfont, Bucks, UK). 
Ultrapure Protogel acrylamide stock solutions were purchased 
from National Diagnostics (Atlanta, GA, USA). For the gener-
ation of peptides, sequencing grade-modified trypsin was 
obtained from Promega (Madison, WI, USA). Protease inhibi-
tors, nitrocellulose sheets and chemiluminescence substrate 
were from Roche Diagnostics (Manheim, Germany), Millipore 
(Bedford, MA, USA) and Pierce and Warriner (Chester, UK), 
respectively. For immunoblotting, primary antibodies were 
purchased from Abcam (Cambridge, UK), (pAb to GAPDH; 
and mAb 46A1 to CK) and Upstate Biotechnology (Lake 
Placid, NY) [mAb SKB1 to protein kinase B (Akt/PKB)]. 
Secondary peroxidase-conjugated antibodies were from 
Chemicon International (Temecula, CA). All other chemicals 
were of analytical grade and obtained from Sigma Chemical 
Company (Dorset, UK).
Animal model of sarcopenia. The gastrocnemius muscle 
from young adult versus aged Wistar rats was used for the 
subproteomic analysis of aging, focusing on proteins with an 
isoelectric point in the basic range. Aged Wistar rat muscle 
is an internationally established model system to study age-
dependent changes in sarcopenia (16). Both human and rodent 
muscles share many common age-related alterations, including 
the incomplete recruitment of distinct fiber groupings, altered 
proportions between slow and fast fibers, altered fiber size, 
tissue degeneration and contractile weakness (5). This makes 
rat muscle an ideal tissue source for detailed proteomic 
studies of muscle wasting associated with aging. Freshly 
dissected muscle specimens from 3- and 30-month-old rats 
were obtained from the Animal Facility of the Department 
of Physiology, Trinity College Dublin, Ireland. For one set of 
comparative proteomic analyses, a combination of 6 biological 
repeats was carried out for each age group. All rats used in 
this study were fed ad libitum and kept at a standard light-dark 
cycle with unrestricted movement in standard animal house 
cages (26). The activity level of the younger rat population was 
enhanced as compared to the older cohort.
Preparation of crude skeletal muscle extracts for electropho-
retic analysis. Fresh muscle tissue (100 mg) was quick-frozen 
in liquid nitrogen and ground into a fine powder using a pestle 
and mortar. The pulverized muscle tissue was resuspended 
in 1 ml of ice-cold buffer (7 M urea, 2 M thiourea, 65 mM 
Chaps, 10 mM Trizma base, 1% ampholytes, 100 mM DTT). 
To avoid protein degradation and eliminate excessive viscosity 
of the extract due to DNA, the solution was supplemented with 
a protease inhibitor cocktail (Roche Diagnostics), and 2 µl of 
DNase-I (200 units, Sigma Chemical Company) was added 
per 100 µl buffer (26). The tissue homogenate was mixed by 
vortexing and was then placed on a bench top shaker for 2.5 h 
at room temperature to precipitate the total protein fraction. 
The suspension was centrifuged at 20,000 x g in an Eppendorf 
5417R centrifuge (Eppendorf, Hamburg, Germany) for 20 min. 
The resulting protein pellet was washed in 5 ml of ice-cold 
100% acetone and thoroughly broken up by vortexing and 
sonication. The centrifugation and washing step was repeated 
twice more with 80% acetone and the final protein precipitate 
was collected by centrifugation and resuspended in 1 ml of the 
above described buffer by gentle pipetting and vortexing. The 
protein lysate was then incubated for 1 h at room temperature, 
whereby samples were vortexed every 10 min for 5 sec, and 
then subjected to IEF.
Offgel electrophoresis. The initial separation of the acidic 
versus the basic protein cohort from rat gastrocnemius muscle 
was carried out with a 3100 OFFGEL Fractionator from 
Agilent Technologies. Protein samples were pre-fractionated 
on 24-well lanes across 24 cm IPG pH 3.0-10.0 strips (35). In 
order to enrich the acidic and the basic portion of the muscle 
sample, proteins from wells 1-12 (acidic samples) and wells 
13-24 (basic samples) were pooled, respectively, upon comple-
tion of IEF. The Agilent 3100 OFFGEL Fractionator performs 
IEF of proteins in immobilized pH gradient strips while the 
separated proteins can then be recovered from the liquid 
phase (36). The offgel electrophoresis procedure was carried 
out according to the manufacturer's guideline using reagents 
supplied with the OFFGEL pH 3.0-10.0 kit from Agilent. 
Fifteen minutes prior to IEF, IPG strips were incubated with 
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40 µl of 1X protein OFFGEL stock solution. Samples were run 
at 1 mg of protein sample/lane for our comparative study of 
young adult versus aged muscle. The sample protein volume 
was brought up to 0.72 ml with ddH2O, and added to 2.88 ml of 
1.25X protein OFFGEL stock solution. A 150-µl aliquot of this 
solution was then added to each well. IEF strips were focused 
in four stages, using 200 V for 90 min, 2,000 V for 90 min, 
3,000 V for 90 min and a final 5,000 V step until the procedure 
reached 64 kV/h. Total focusing time depended mainly on the 
number of strips being focused and could take up to 72 h when 
12 strips were run simultaneously. Every 24 h the wicks on 
each strip were removed and replaced with new wicks wetted 
with distilled water. Upon completion of IEF, samples from 
the two different pH-ranges were removed and pooled. Excess 
urea, which was found to interfere with the acetone precipita-
tion of protein, was removed by repeated dialysis. Samples 
were acetone precipitated (26) and resuspended in 200 µl of 
rehydration buffer (7 M urea, 2 M thiourea, 65 mM Chaps, 1% 
ampholytes pH 3.0 to 10.0 and 10 mg/ml DTT).
Two-dimensional (2D) gel electrophoretic analysis. In order 
to analyze pre-fractionated proteins with an isoelectric point 
in the basic range, 2D gel electrophoresis was carried out as 
previously described in detail by our laboratory (19,26,28). 
Following IEF with an Amersham IPGphor system with the 
following running conditions: 30 V for 2 h, 500 V for 2.5 h, 
1,000 V for 1 h, 2,000 V for 1 h, 4,000 V for 1 h, 6,000 V 
for 1 h, 800 V for 3 h, 500 V for 1.5 h and finally 8,000 V 
for 2.5 h, samples were equilibrated and washed in running 
buffer (26), and then separated in the second dimension with 
12% resolving gels in a Protean Xi-ll cell from Bio-Rad 
Laboratories (Hemel-Hemstead, Hertz, UK). Sodium dodecyl 
sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) was 
carried out for 2 h at 30 V and a subsequent 80 V step until the 
bromophenol blue dye front ran off the gel. Silver staining of 
2D gels was carried out by the method of Chevallet et al (38). 
For image analysis, 6 gels representing young adult muscle and 
6 gels representing aged muscle were scanned using Image 
Scanner II from Amersham Bioscience/GE Healthcare. Images 
were analyzed with Progenesis SameSpots analysis software 
from Nonlinear Dynamics (Newcastle upon Tyne, UK).
Mass spectrometric (MS) identification of basic muscle 
proteins. Protein identification was carried out by MS analysis 
of peptides with a Model 6340 Ion Trap LC/MS apparatus from 
Agilent Technologies. Excision, washing, destaining and treat-
ment with sequencing-grade trypsin were performed using an 
optimized method as previously described by our laboratory 
(28,30). Trypsin-generated peptides were resuspended in 30 µl 
of ultrapure ddH2O and 0.1% formic acid for ion trap LC-MS 
analysis. Separation of peptides was performed with a Nanoflow 
Agilent 1200 series system (Agilent Technologies), equipped 
with a Zorbax 300SB C18 5 µm, 4 mm 40 nl pre-column and an 
Zorbax 300SB C18 5 µm, 43 mm x 75 µm analytical reversed 
phase column using HPLC-Chip technology. Mobile phases 
utilized were A, 0.1% formic acid; B, 50% acetonitrile and 0.1% 
formic acid. Samples (15 µl) were loaded into the enrichment 
at a capillary flow rate set to 4 µl/min with a mix of A and B at 
a ratio 19:1. Tryptic peptides were eluted with a linear gradient 
of 10-90% solvent B over 40 min with a constant nano pump 
flow of 0.60 ml/min. A 10 min post time of solvent A was used 
to remove sample carryover. The capillary voltage was set to 
1,700 V. The flow and the temperature of the drying gas was 
4 l/min and 300˚C, respectively. For muscle protein identifica-
tion, database searches were carried out with Mascot MS/MS 
Ion search (Matrix Science, London, UK). All searches used 
ʻRattus norvegicus’ as taxonomic category and the following 
parameters: i) two missed cleavages by trypsin, ii) mass toler-
ance of precursor ions ± 2.5 Da and product ions ± 0.7 Da, iii) 
carboxymethylated cysteine fixed modification and iv) oxida-
tion of methionine as variable modification. In addition, 
the percentage coverage was set at over 10%, with at least 2 
matched distinct peptide and a Mascot score of over 60.
Immunoblot analysis. For the verification of changes in select 
marker proteins, immunoblotting was used to determine 
potential changes in proteins in young adult versus aged muscle 
preparations (26). The electrophoretic transfer of proteins to 
Immobilon NC-Pure nitrocellulose membranes was carried 
out with a Mini-Protean II transfer system from Bio-Rad 
Laboratories (Hemel-Hempstead, Herts, UK). Following 
transfer for 1 h at 100 V and 4˚C, the efficiency of transfer 
was evaluated by Ponceau-S-Red staining of membranes, 
followed by de-staining in phosphate-buffered saline 
(PBS, 50 mM sodium phosphate, 0.9% (w/v) NaCl, pH 7.4). 
Protein-containing nitrocellulose membranes were blocked 
for 1 h in 5% (w/v) fat-free milk powder in PBS and incubated 
for 3 h at room temperature with appropriately diluted primary 
antibodies to GAPDH, CK or Akt/PKB. Following washing in 
blocking solution, sheets were incubated with an appropriate 
dilution of peroxidase-conjugated secondary antibody for 
1 h at room temperature, washed again in blocking solution 
and PBS, and finally immuno-decorated protein bands were 
visualized using the SuperSignal-Type enhanced chemilum-
inecence system from Pierce and Warriner (Chester, Cheshire, 
UK). Densitometric scanning of immunoblots was performed 
on a Molecular Dynamics 300S computing densitometer 
(Sunnyvale, CA, USA) with Imagequant V3.0 software.
Results
Certain muscle proteins with an isoelectric point in the 
basic range are underestimated in gel electrophoresis-based 
proteomic studies. Therefore, to address this technical issue, 
we performed a comparative subproteomic investigation 
of young adult versus aged rat muscle focusing on potential 
changes in muscle proteins with an alkaline isoelectric point. 
The combination of offgel electrophoresis and 2D gel electro-
phoresis is outlined in Fig. 1 and the separation patterns in the 
basic pH-range are shown in Fig. 2 that compares young adult 
versus aged muscle specimens. A mastergel of proteins with 
age-related changes in abundance and their mass spectrometric 
identification is presented in Fig. 3 and Table I. Verification 
of proteomic data is provided by comparative immunoblot 
analysis of select marker proteins (Fig. 4).
Offgel electrophoretic separation of the skeletal muscle 
proteome. In order to improve protein separation in the basic 
pH-range, offgel electrophoresis was employed as a pre-
fractionation step. Running conditions were optimized with 
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respect to loading volume and protein amounts needed for 
a proper offgel electrophoresis-based separation of muscle 
proteins (data not shown). An amount of 1 mg protein/lane 
resulted in an acceptable rate of protein recovery following 
offgel electrophoresis, dialysis and acetone precipitation for 
protein fractionation, removal of access urea and protein 
concentration, respectively. Fig. 1 outlines the various experi-
mental steps used in the analysis of the basic protein cohort 
from young versus aged gastrocnemius muscle. The silver-
stained 2D gels of the acidic complement versus the basic 
cohort of urea-soluble muscle proteins show a comparable 
protein separation for the pH 4.0-7.0 range and an improved 
separation pattern for the pH 6.0-9.0 range, as compared to 
previously published 2D maps of crude skeletal muscle prepa-
rations (24-26).
Gel electrophoretic comparison of young adult versus aged 
skeletal muscle. The 2D gels presented in Fig. 2 illustrate the 
expression pattern of basic proteins from young adult versus 
aged rat gastrocnemius muscle. Both gels show a relatively 
comparable 2D protein spot distribution in the pH 6.0-11.0 
range. In order to determine potential changes in abundance in 
individual protein spots, gels were analyzed with Progenesis 
SameSpots analysis software. The densitometric analysis of 
the 2D gels revealed 12 muscle-associated proteins with an 
altered abundance. Of these differentially expressed protein 
species, 6 protein isoforms could unequivocally be identified 
by MS.
Mass spectrometric (MS) identification of muscle proteins 
with an age-related change in abundance. The representa-
tive mastergel in Fig. 3 shows the 6 identified proteins that 
differed in their abundance between young adult and senescent 
muscle preparations. Proteins ranged in molecular mass from 
36-48 kDa and exhibited an isoelectric point from pI 6.6-9.1. 
Table I lists spot numbers, protein accession numbers, name 
of identified proteins, number of matched peptides, peptide 
sequences, sequence coverage, molecular mass, isolectric 
point, Mascot score and fold-change of individual protein 
species during aging. Listed are muscle-associated protein 
with a Mascot score above 60. Protein spots with an increased 
density were identified as two key mitochondrial components, 
the mitochondrial isoform of CK (spot 1) and ubiquinol cyto-
chrome-c reductase (spot 2). A reduction was shown for the 
muscle-type CK (spot 3) and the glycolytic enzyme GAPDH 
(spots 4-6).
Immunoblot analysis of marker proteins in aging skeletal 
muscle. In order to verify the differential expression of 
muscle-associated components that was identified by our 
proteomic survey of basic proteins, immunoblotting was 
carried out. Fig. 4 illustrates the immuno-decoration of CK 
versus GAPDH, as well as Akt/PKB as a loading control. In 
agreement with the proteomic establishment of an increased 
level of mitochondrial CK and a decreased concentration of 
GAPDH, immunoblot analysis showed a significant elevation 
of the mitochondrial enzyme and suggests a reduced presence 
of the glycolytic protein in aged skeletal muscle.
Discussion
As the primary site for energy generation via oxidative phos-
phorylation, mitochondria play a key role in skeletal muscle 
metabolism. In addition, this class of organelle is involved 
in protein transportation, cell cycle progression, calcium 
handling, intermediary metabolism and apoptotic regulation 
(39). Alterations in the abundance and/or post-translational 
modifications of mitochondrial enzymes are believed to be 
involved in the natural aging process (40). In addition, altered 
concentration levels of mitochondrial enzymes from skeletal 
muscle are often an indication of fiber type shifting during 
physiological or pathophysiological muscle adaptations (41). In 
this respect, the findings presented in this subproteomic survey 
of basic proteins in young adult versus senescent rat gastrocne-
mius muscle support the idea of a glycolytic-to-oxidative shift 
during skeletal muscle aging. The mass spectrometric identi-
fication of altered basic proteins has established an increase in 
two key mitochondrial enzymes, ubiquinol cytochrome-c reduc-
tase core protein 2 and mitochondrial CK and a concomitant 
Figure 1. Analytical work-flow diagram for studying the basic protein changes 
during skeletal muscle aging. Shown is a flow diagram of the pre-fractionation 
approach using offgel electrophoresis in order to enrich for muscle proteins 
with a basic pI-value. Shown are representative silver-stained 2D gels of the 
acidic vs. alkaline range of proteins following separation by offgel electropho-
resis. The subproteomic analysis of young adult vs. aged muscle proteins was 
then performed by 2D gels employing a pH 6.0-11.0 range.
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decrease in the glycolytic marker enzyme GAPDH in senescent 
rat muscle. This metabolic shift would imply a fast-to-slow 
muscle transformation process during age-related adaptations 
of contractile fibers. The mitochondrial and glycolytic aging 
markers identified in this study are enzymes with well-charac-
terized metabolic functions. CK is a key metabolic enzyme of 
the mitochondrial inter-membrane space and is involved in the 
production of creatine phosphate from mitochondrial ATP and 
cytosolic creatine (42). Ubiquinol cytochrome-c reductase is 
an essential subunit of the cytochrome-bc1 complex, making 
it a crucial element of the mitochondrial respiratory chain 
(43). GAPDH is a key enzyme of the glycolytic pathway that 
converts glyceraldehyde-3-phosphate to 1,3-bisphosphoglyc-
erate and generates NADH (44).
Previous proteomic studies of both human and animal 
muscles have shown a general trend of muscle transitions 
to more aerobic-oxidative metabolism in a slower-twitching 
aged fiber population (22-30). This would agree with the 
results of the subproteomic analysis of basic muscle proteins 
presented in this study. Aged muscle fibers are under consider-
able oxidative stress and exhibit mitochondrial abnormalities 
(45-47). Importantly, changes in the abundance of mitochon-
drial versus glycolytic enzymes are often accompanied by 
shifts in fiber type distribution patterns of individual muscles 
(48). For example, chronic low-frequency stimulation trig-
gers a gradual shift towards slower isoforms of contractile 
and calcium handling proteins, as well as a drastic increase 
in mitochondrial enzymes (49). The same alterations in 
metabolic enzymes have been described in the case of patho-
logical fiber type transitions. The proteomic profiling of the 
ADR mouse model of myotonia has clearly shown increased 
levels of mitochondrial enzymes in hyper-excitable muscle 
tissue (50). With respect to sarcopenia, the exact extent of a 
glycolytic-to-oxidative shift and accompanying fast-to-slow 
muscle transformation process is still the subject of intense 
debate in the field of biogerontology. Both human and animal 
Figure 2. Comparative 2D gel electrophoretic analysis of basic proteins during skeletal muscle aging. Shown are 2D gels of young adult vs. aged rat gastroc-
nemius muscle preparations. The pH-values of the first dimension gel system and molecular mass standards (in kDa) of the second dimension are indicated on 
the top and on the left of the panels, respectively.
Figure 3. Proteomic identification of altered proteins during skeletal muscle 
aging. Shown is a representative 2D mastergel of proteins with differential 
expression in aged rat gastrocnemius muscle. Identified protein spots are 
numbered 1-6 and their mass spectrometric identification is listed in Table I. 
The pH-values of the first dimension gel system and molecular mass stan-
dards (in kDa) of the second dimension are indicated on the top and on the 
left of the panels, respectively.
Figure 4. Verification of select proteomic data by immunoblotting. Shown 
is an expanded view of immuno-decorated bands from young adult (Y) vs. 
old (O) skeletal muscle preparations, representing (A) creatine kinase (CK), 
(B) glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and (C) Akt/PKB, 
respectively. The comparative immunoblot analysis was statistically evalu-
ated using an unpaired Student's t-test (n=6, **P<0.01).
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skeletal muscles show changes in their molecular and cellular 
constellation and clearly exhibit alterations in their glyco-
lytic and aerobic capacity. However, large-scale histological 
surveys of potential alterations in fiber type distributions with 
aging have shown variable results (51-54). The results from 
this report have clearly demonstrated differential changes 
in the abundance of mitochondrial and glycolytic marker 
proteins during rat skeletal muscle aging.
Muscle aging appears to be associated with a plethora of 
cellular and functional abnormalities, including: i) impaired 
neuromuscular transmission resulting in the loss of entire 
motor units and cycles of denervation and impaired reinnerva-
tion (4), ii) the uncoupling between plasmalemmal excitation 
and fiber contraction (55), iii) altered functioning of the acto-
myosin apparatus causing a decline in contractile efficiency 
(56), iv) an altered equilibrium of growth factors and hormones 
involved in the maintenance of muscle contraction (57), v) 
denervation-associated atrophy (2), vi) increased apoptosis 
(58), vii) impaired regulation of bioenergetic processes (59), 
viii) disturbed ion handling (60), ix) increased Ca2+-dependent 
calpain activity triggering mitochondrial and cytoskeletal 
dysfunction (61), x) a drastically decreased capacity for 
cellular regeneration (62) and xi) a diminished stress response 
by molecular chaperones (63). Here, we confirm the idea 
that a glycolytic-to-oxidative shift occurs in skeletal muscle 
metabolism during the natural aging process. In the future, 
the identified mitochondrial and glycolytic enzymes could 
be useful as potential biomarkers of fiber aging. Since mito-
chondria are of central importance for energy generation in 
contractile fibers and because alterations in the density and/or 
function of mitochondrial enzymes are generally involved in 
muscle development, muscle differentiation, fiber adaptations 
and a variety of muscle diseases, the establishment of reliable 
biomarker signatures is crucial. As shown here, MS-based 
subproteomics represents a convenient large-scale approach to 
identify mitochondrial markers of muscle aging.
In conclusion, since large-scale surveys of fiber type 
distributions during muscle aging have resulted in variable 
findings, it was of interest to determine potential changes 
in the abundance of mitochondrial and glycolytic marker 
proteins in aged skeletal muscle by subproteomics. We 
showed here that a glycolytic-to-oxidative shift occurs in an 
animal model of sarcopenia, the 30-month-old Wistar rat. 
In the long-term, the systematic cataloguing of age-related 
alterations in the concentration, post-translational modifica-
tions, physiological functioning and subcellular localization of 
mitochondrial enzymes might be useful for the establishment 
of a comprehensive biomarker signature of skeletal muscle 
aging. International working groups on skeletal muscle aging 
have not yet fully established a definition and agreed clinical 
assessment of sarcopenia as a common geriatric syndrome 
(64-66). It is therefore crucial to identify and characterize reli-
able biomarkers of sarcopenia of old age (67). Once suitable 
combinations of marker enzymes have been characterized, 
they might be useful for improving diagnostic procedures to 
differentiate mild versus severe forms of sarcopenia, advance 
biomedical approaches for monitoring disease progression, 
expand the set of bioanalytical tools for testing potential 
side effects of new drug regimes and shed new light on the 
molecular pathogenesis of sarcopenia of old age.
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